KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹11 Cr | ₹0.69 Cr | ₹1.53 Cr | ₹4.93 Cr | ₹0.10 Cr |
What is the latest Net Cash Inflow / Outflow ratio of KOPRAN ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹0.69 Cr |
| Mar2023 | ₹1.53 Cr |
| Mar2022 | ₹4.93 Cr |
| Mar2021 | ₹0.10 Cr |
How is Net Cash Inflow / Outflow of KOPRAN Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | 1,537.70 | |
| Mar2024 | ₹0.69 Cr | -54.52 | |
| Mar2023 | ₹1.53 Cr | -69.02 | |
| Mar2022 | ₹4.93 Cr | 4,784.16 | |
| Mar2021 | ₹0.10 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹700.6 Cr | -3.9% | 10.9% | -26.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -3.9% |
10.9% |
-26.1% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses